361 related articles for article (PubMed ID: 19631411)
1. [The value of MELD in the allocation of priority for liver transplantation candidates].
Colmenero J; Castro-Narro G; Navasa M
Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
[TBL] [Abstract][Full Text] [Related]
2. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
4. Application of a continuous disease severity score to the OPTN liver waiting list.
Edwards EB; Harper AM
Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
[TBL] [Abstract][Full Text] [Related]
5. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
6. The MELD score in patients awaiting liver transplant: strengths and weaknesses.
Bernardi M; Gitto S; Biselli M
J Hepatol; 2011 Jun; 54(6):1297-306. PubMed ID: 21145851
[TBL] [Abstract][Full Text] [Related]
7. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
[TBL] [Abstract][Full Text] [Related]
8. Selection of candidates with HCC for transplantation in the MELD era.
Sala M; Varela M; Bruix J
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
[TBL] [Abstract][Full Text] [Related]
9. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
10. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
[TBL] [Abstract][Full Text] [Related]
11. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
12. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list.
Castro RS; Deisanti D; Seva-Pereira T; Almeida JR; Yamanaka A; Boin IF; Soares EC
Transplant Proc; 2010 Mar; 42(2):412-6. PubMed ID: 20304153
[TBL] [Abstract][Full Text] [Related]
13. Liver transplant recipient selection: MELD vs. clinical judgment.
Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
[TBL] [Abstract][Full Text] [Related]
14. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience.
de la Mata M; Cuende N; Huet J; Bernardos A; Ferrón JA; Santoyo J; Pascasio JM; Rodrigo J; Solórzano G; Martín-Vivaldi R; Alonso M
Transplantation; 2006 Dec; 82(11):1429-35. PubMed ID: 17164713
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
Ioannou GN; Perkins JD; Carithers RL
Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
[TBL] [Abstract][Full Text] [Related]
17. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
Heuman DM; Mihas AA; Habib A; Gilles HS; Stravitz RT; Sanyal AJ; Fisher RA
Liver Transpl; 2007 Jan; 13(1):30-7. PubMed ID: 17154400
[TBL] [Abstract][Full Text] [Related]
18. MELD-based liver allocation: who is underserved?
Biggins SW; Bambha K
Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
[TBL] [Abstract][Full Text] [Related]
19. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
[TBL] [Abstract][Full Text] [Related]
20. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
Monteiro F; Coria SA; Boni R; Pereira LA
Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]